You are here: Industry Insights > Alcami

News List

Alcami Expands Biologics Footprint with Investment in Durham contractpharma
January 28, 2022
$10 million investment doubles laboratory footprint and enhances large molecule and cell and gene therapy analytical service offering.
Alcami Acquires Masy BioServices contractpharma
December 16, 2021
Adds 375,000 sq.-ft. of cGMP biostorage and pharma support services.
Alcami Inks Lab Services Agreement with Novavax ContractPharma
November 17, 2021
Alcami, a U.S.-based CDMO, has signed a master laboratory services agreement with Novavax, a biotechnology company developing next-generation vaccines for infectious diseases.
Alcami to manufacture PharmaTher’s proprietary ketamine products CPhIonline
October 25, 2021
Three weeks after Alcami announced it was investing an additional $31 million to expand its sterile CDMO operation in Charleston, SC to increase its fill-finish and lyophilisation capacity...
Alcami Appoints Timothy Compton Chief Business Officer contractpharma
August 11, 2021
Mr. Compton brings more than 25 years of industry experience leading high-performing business teams.
Alcami Names Patrick D. Walsh as Chairman and CEO contractpharma
March 22, 2021
Alcami, a global pharmaceutical CDMO, has appointed Patrick D. Walsh as chairman and chief executive officer, effective immediately. He succeeds Walter J. Kaczmarek III, who is stepping down as chief executive.
Alcami Appoints Patrick D. Walsh as Chairman and Chief Executive Officer contractpharma
March 19, 2021
Alcami, a global pharmaceutical contract development and manufacturing organization (CDMO), announced that its Board of Directors has appointed Patrick D. Walsh as Chairman and Chief Executive Officer, effective immediately.
Alcami Expands Oral Solid Capabilities contractpharma
January 12, 2021
Alcami, a U.S.-based contract development and manufacturing organization (CDMO), announced an additional $2 million investment to expand its oral solid development and manufacturing capabilities in Wilmington, NC.
Alcami, Trevana Enter Manufacturing Pact contractpharma
September 02, 2020
CDMO Alcami providing commercial manufacturing for recently FDA approved OLINVYK.
Alcami Names New CEO contractpharma
June 05, 2020
30-year pharma vet Walter J. Kaczmarek III takes the helm at the CDMO.

Previous page 1 2 Next page